FREE Account Opening + No Clearing Fees
Loading...
May 3, 2019 - May 8, 2019

Par Drugs IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Par Drugs IPO.

Par Drugs IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 1 0 0 0
% 0.00 100.00 0.00 0.00 0.00

Par Drugs IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Dilip Davda May Apply

Par Drugs IPO Review by Dilip Davda (May apply)

[Dilip Davda]  Investors may consider investment for the long term. Based on financial parameters (including P/BV data) issue appears reasonably priced. Promoters have converted shares at Rs. 66 while the issue is priced lower. Employees too are offered shares at the same price of IPO. Read detail review...

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.